Mobile will help transform our fragmented health care system and reorient it around consumers.

The promise and challenges of semaglutide, a new therapy for weight loss

With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.

Today, as technology becomes an evermore integral part of our lives, it is being utilized in numerous ways to improve health care, providing convenience and access while assisting providers and enhanc...

The complex nature of copay assistance programs requires operational agility on the part of specialty pharmacies.

Accredo employs more than 800 specialty pharmacists who are dedicated to educating and assisting patients with rare or complex conditions.

All too often, a person’s gender, race, education, income or zip code dictates how healthy they are.

GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...

Uncover six common misconceptions about self-pay pharmacies and learn why pharmacy benefit managers (PBMs) often provide more affordable, accessible, and clinically appropriate care.

Breaking down what plan sponsors should know about HAE, its challenges and therapies.